Cargando…

A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States

BACKGROUND: This cross-sectional study aimed to track population-based SARS-CoV-2 antibody seropositivity duration across the United States using observational data from a national clinical laboratory registry of patients tested by nucleic acid amplification (NAAT) and serologic assays. Knowledge of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alfego, David, Sullivan, Adam, Poirier, Brian, Williams, Jonathan, Adcock, Dorothy, Letovsky, Stanley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143650/ https://www.ncbi.nlm.nih.gov/pubmed/34056568 http://dx.doi.org/10.1016/j.eclinm.2021.100902

Ejemplares similares

Follow-Up SARS-CoV-2 PCR Testing Outcomes From a Large Reference Lab in the US
por: Sullivan, Adam, et al.
Publicado: (2021)

Antibody titer levels and the effect on subsequent SARS-CoV-2 infection in a large US-based cohort
por: Sullivan, Adam, et al.
Publicado: (2023)

Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States
por: Kalish, Heather, et al.
Publicado: (2021)

Longevity of seropositivity after anti SARS-CoV-2 vaccination in patients awaiting liver transplant
por: Calleri, A., et al.
Publicado: (2022)

Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
por: Liu, Anding, et al.
Publicado: (2020)

Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database
por: Alfego, David, et al.
Publicado: (2021)

Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States—October 25, 2020–February 26, 2022
por: Wiegand, Ryan E., et al.
Publicado: (2022)

Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study
por: Cheon, Shinhye, et al.
Publicado: (2022)

Comparative evaluation and longevity of neutralising and binding antibodies for SARS-COV-2
por: Davidson, Natalie, et al.
Publicado: (2021)

Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
por: Kalish, Heather, et al.
Publicado: (2021)

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
por: Harvey, Raymond A., et al.
Publicado: (2021)

Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects
por: Saker, Kahina, et al.
Publicado: (2022)

SARS CoV-2 seropositivity in haemodialysis patients
por: Toapanta, Nestor, et al.
Publicado: (2022)

Comparison of nucleocapsid and spike antibody ELISAs for determining SARS‐CoV‐2 seropositivity in Kenyan women and infants
por: Fish, Carolyn S., et al.
Publicado: (2022)

SARS-CoV-2 Seropositivity among US Marine Recruits Attending Basic Training, United States, Spring–Fall 2020
por: Letizia, Andrew G., et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study
por: Muro, Antonio, et al.
Publicado: (2021)

Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients
por: Amodio, Emanuele, et al.
Publicado: (2021)

Population-based seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city
por: Prakash, Om, et al.
Publicado: (2021)

Prevalence and Longevity of SARS-CoV-2 Antibodies Among Health Care Workers
por: Brant-Zawadzki, Michael, et al.
Publicado: (2021)

Household Socioeconomic and Demographic Correlates of Cryptosporidium Seropositivity in the United States
por: Becker, Daniel J., et al.
Publicado: (2015)

SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
por: Tea, Fiona, et al.
Publicado: (2021)

SARS-CoV-2 Antibody Seroprevalence Among Maintenance Dialysis Patients in the United States
por: Walker, Adam G., et al.
Publicado: (2021)

Ingesting Self-Grown Produce and Seropositivity for Hepatitis E in the United States
por: Diehl, Thomas M., et al.
Publicado: (2018)

Diagnostic accuracy of three SARS-CoV2 antibody detection assays, neutralizing effect and longevity of serum antibodies
por: Bubonja-Šonje, Marina, et al.
Publicado: (2021)

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
por: Krammer, Florian, et al.
Publicado: (2021)

Seropositivity of SARS-CoV-2 IgG Antibody among People in Dhaka City during the Prevaccination Period
por: Ahmed, Zabed Bin, et al.
Publicado: (2022)

SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants
por: Kubale, John, et al.
Publicado: (2022)

Seropositivity of Dengue Antibodies during Pregnancy
por: Mohamed Ismail, Nor Azlin, et al.
Publicado: (2014)

488. SARS-CoV-2 Preparedness among Community Hospitals in Southeastern United States
por: Advani, Sonali D, et al.
Publicado: (2020)

Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022
por: Clarke, Kristie E.N., et al.
Publicado: (2022)

Regional and Temporal Variations of Leptospira Seropositivity in Dogs in the United States, 2000–2010
por: Lee, H.S., et al.
Publicado: (2014)

High rates of SARS-CoV-2 seropositivity in nursing home residents
por: NSN, Graham, et al.
Publicado: (2021)

RISK FACTOR ANALYSIS FOR SARS-COV-2 SEROPOSITIVITY WITHIN ASSISTED REPRODUCTIVE
por: Prados, Nicolás, et al.
Publicado: (2020)

Evaluation and Transplantation of a SARS-CoV-2 Seropositive Kidney Candidate
por: Graves, Maya C., et al.
Publicado: (2021)

Persistence of infection-induced SARS-CoV-2 seropositivity throughout gestation
por: Staszewski, Cara, et al.
Publicado: (2022)

Anti-SARS-CoV-2 Seropositivity Among Medical Students in Copenhagen
por: Madsen, Johannes R, et al.
Publicado: (2021)

Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua
por: Kubale, John, et al.
Publicado: (2022)

436. SARS-CoV-2 Seropositivity and Association with Dengue Severity in Adults
por: Priyadarshi, Megha, et al.
Publicado: (2023)

Seroprevalence of antibodies to SARS-CoV-2 and predictors of seropositivity among employees of a teaching hospital in New Delhi, India
por: Sharma, Pragya, et al.
Publicado: (2021)

Delayed seropositivity is associated with lower levels of SARS-CoV-2 antibody levels in patients with mild to moderate COVID-19
por: Fekry, Marwa M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e9bhv8hl84dan37r0g4p64qr9i